U.S., India, Japan and Australia develop vaccine pact to supply Asia, counter China
WASHINGTON (Reuters) - The United States and three of its closest Indo-Pacific partners committed to supplying up to a billion coronavirus vaccine doses across Asia by the end of 2022 at a summit on Friday carefully choreographed to counter China’s growing influence.
President Joe Biden and the leaders of Australia, India and Japan - countries together known as the Quad - pledged at their first summit to work to ensure a free and open Indo-Pacific and to cooperate on maritime, cyber and economic security, issues vital to the four democracies in the face of challenges from Beijing.
“We’re renewing our commitment to ensure that our region is governed by international law, committed to upholding universal values, and free from coercion,” Biden told his counterparts, without naming China.
His national security adviser, Jake Sullivan, called the virtual summit a big day for U.S. diplomacy, as Washington sought to revitalize its alliances and approach Beijing from a position of strength ahead of a high-level U.S.-China meeting next week.
“The four leaders did discuss the challenge posed by China, and they made clear that none of them have any illusions about China,” Sullivan told reporters, adding that they all believed democracy could outcompete “autocracy.” ...
In a joint statement, Biden, Japanese Prime Minister Yoshihide Suga, Indian Prime Minister Narendra Modi, and Australian Prime Minister Scott Morrison, pledged to work closely on COVID-19 vaccine distribution, climate and security.
“We strive for a region that is free, open, inclusive, healthy, anchored by democratic values, and unconstrained by coercion,” they added.
The leaders agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change, technology standards, and joint development of emerging technologies. An in-person summit would be held later this year, they said...
India’s Foreign Secretary Harsh Vardhan Shringla said the summit had agreed U.S. vaccines would be manufactured in India, something New Delhi has called for to counter Beijing’s widening vaccine diplomacy.
A Quad fact sheet said the United States, through its International Development Finance Corp, would work to finance Indian drugmaker Biological E Ltd to produce at least 1 billion COVID-19 vaccine doses by the end of 2022.
It also said Japan was in discussions to provide concessional yen loans for India to expand manufacturing of COVID-19 vaccines for export.
Sullivan said the vaccines would go to Southeast Asian countries, elsewhere in the Indo-Pacific, and beyond. ...
